SALARIUS PHARMACEUTICALS INC (SLRX) Stock News

NASDAQ:SLRX - US79400X4043 - Common Stock

5.62 USD

-0.15 (-2.6%)

Last: 8/25/2025, 8:00:02 PM

5.62 USD

0 (0%)

After Hours: 8/25/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SLRX Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split

15 days ago - By: Benzinga - Mentions: OMI REPL XCUR TLRY ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

25 days ago - By: Benzinga - Mentions: CCCS IXHL AAPL RAYA ...

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

a month ago - By: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard

2 months ago - By: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies

4 months ago - By: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board